期刊文献+

慢病毒载体转录通读率检测方法的建立 被引量:1

Establishment of the methodology for quantifying lentiviral vector transcriptional read-through rate
原文传递
导出
摘要 慢病毒载体作为一种有效的生物研究和基因治疗载体,近年来正受到广泛关注,而转录通读现象则是限制其被使用的主要生物安全性瓶颈之一。为了评估慢病毒载体在整合入染色体后的转录通读的实际情况,需要建立一种有效的检测转录通读率的方法。文中运用分子生物学等手段,将相关质粒瞬时转染入293T细胞,模拟野生型和自灭活型慢病毒载体整合入染色体后的情况,利用实时荧光定量PCR分别定量转录通读和总转录本在慢病毒载体上的特征序列,并计算出转录通读率;同时使用流式细胞计数等技术,检测转录通读后的GFP蛋白产物。两种检测结果均与理论相符,即自灭活型载体具有更高的转录通读率。说明文中所建立的方法有效可靠,为进一步评估和降低慢病毒载体的转录通读率,提高慢病毒载体的生物安全性的研究提供技术支持。 As an effective vehicle for bio-research and for gene therapy,Lentiviral Vector(LV) has been drawn large attention in recent years.However,transcriptional read-through limits its application.In order to understand the extend of LV read-through in chromosome,a reliable method to assess transcriptional read-through rate is needed.Here,we report the method as follows: 293T cells were transfected with the lentiviral transfer vectors which borne with two LTRs at its two ends in order to mimic the state of "proviral vectors" in chromosome.Using the primers specific for 3'U5 and 3'U3,read-through and total transcripts were reverse transcribed,respectively.These two cDNAs were quantified by realtime PCR using the primers and probe specific for 5'end of 3'U3.Read-through rate was then calculated by the division of the two.Meanwhile,read-through product of green fluorescence protein was also analyzed by Fluorescence Activated Cell Sorter.They both reciprocally proved the principal and confirmed that self-inactivated LV appeared higher read-through rate than the wild type one.The method described in this article,therefore,provides a useful technique to study how to reduce read-through rate,and improve the bio-safety of LV.
出处 《生物工程学报》 CAS CSCD 北大核心 2013年第7期1006-1015,共10页 Chinese Journal of Biotechnology
基金 国家自然科学基金(No.81271690) 国家重大基础研究发展计划(973计划)(No.2010CB945202) 上海市自然科学基金(No.11ZR1429900)资助~~
关键词 慢病毒载体 自灭活慢病毒载体 转录通读率 安全性 lentiviral vector self-inactivating lentiviral vector transcriptional read-through rate safety
  • 相关文献

参考文献22

  • 1Yang Q,Lucas A,Son S,et al. Overlappingenhancer/promoter and transcriptional terminationsignals in the lentiviral long terminal repeat.Retrovirology,2007,4(4):1-8.
  • 2Zaiss A,Son S,Chang L. RNA 3'readthrough ofoncoretrovirus and lentivirus:implications forvector safety and efficacy. J Virol,2002,76(14):7209-7219.
  • 3Ramezani A,Hawley TS,Hawley RG.Combinatorial incorporation of enhancer blockingcomponents of the chicken (3-globin 5'HS4 andhuman T-cell receptor a/8BEAD-l insulators inself-inactivating retroviral vectors reduces theirgenotoxic potential. Stem Cells,2008,26(12):3257-3266.
  • 4Chang L,Ding X,George S,et al. Genomic andfunctional assays demonstrate reducedgammaretroviral vector genotoxicity associatedwith use of the cHS4 chromatin insulator. MolTher,2009,17(4):717-724.
  • 5Paritha 1,Tomoyasu H,Fabrizia U,et al. Genotoxicpotential of lineage-specific lentivirus vectorscarrying the p-globin locus control region. MolTher,2009,17(11):1929-1937.
  • 6Ramezani A,Hawley TS,Hawley RG. Reducingthe genotoxic potential of retroviral vectors.Methods Mol Biol,2008,434:183-203.
  • 7Hideki H,Motoko Y,Huifen Z,et al. Optimizedlentiviral vector design improves titer andtransgene expression of vectors containing thechicken p-globin locus HS4 insulator element. MolTher,2009,17(4):667-674.
  • 8马海燕,方彧聃,张敬之.应用荧光实时定量PCR方法检测重组慢病毒滴度及其感染效率[J].生命科学研究,2009,13(5):394-398. 被引量:14
  • 9Poznansky M,Lever A,Bergeron L,et al. Genetransfer into human lymphocytes by a defectivehuman immunodeficiency virus type 1 vector. JVirol,1991,65(1):532-536.
  • 10Naldini L,Blomer U,Gallay P,et al. In vivo genedelivery and stable transduction of nondividingcells by a lentiviral vector. Science,1996,272(5259):263-265.

二级参考文献14

  • 1张敬之,郭歆冰,谢书阳,朱怡文,黄英,王舒,任兆瑞.用慢病毒载体介导产生绿色荧光蛋白(GFP)转基因小鼠[J].自然科学进展,2006,16(5):571-577. 被引量:25
  • 2WU X, LI Y, CRISE B, et al. Transcription start regions in the human genome are favored targets for MLV integration[J]. Science, 2003,300: 1749-1751.
  • 3DEPALMA M, MONTINI E, SANTONIDESIO F R, et al. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells[J]. Blood, 2005,105(6): 2307-2315.
  • 4SCHRODER A R, SHINN P, CHEN H, et al. HIV-1 integration in the human genome favors active genes and local hotspots[J]. Cell, 2002, 110: 521-529.
  • 5JAKOBSSON J, ERICSON C, JANSSON M, et al. Targeted transgene expression in rat brain using lentiviral vectors[J]. Neurosci Res, 2003, 73(6): 876.
  • 6STEWART S A, OYLOCHOOM D M, PALLISER D, et al. Lentivims-delivered stable gene silencing by RNAi in primary cells[J]. RNA, 2003, 9(4): 493-501.
  • 7MAY C, RIVELLA S, CALLEGARI J, et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin[J]. Nature, 2000, 406 (6791): 82-86.
  • 8HAN X D, LIN C, CHANG J, et al. Fetal gene therapy of α-thalassemia in a mouse model[J]. PNAS, 2007, 104(21): 9007-9011.
  • 9LI W, XIE S Y, GUO X B, et al. A novel transgenic mouse model produced from lentiviral germline integration for the study of β-thalassemia gene therapy[J]. Haematologica, 2008, 93(3): 357-362.
  • 10LOIS C, HONG E J, PEASE S, et al. Germline transmission and tissuespecific expression of transgenes delivered by lentiviral vectors[J]. Science, 2002, 295: 868-872.

共引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部